The market pulled back on Monday as investors took profits after last week's 6% runup.

Telecom giants AT&T (T) and Verizon Communications (VZ) both fell on news of an expected decrease in cell phone sales. Financials also lagged the market as JPMorgan (JPM) and Citigroup (C) had their estimates cut.

But not all news was bad.

Auto stocks moved both ways after reporting better than expected December sales numbers. Shares of General Motors (GM) and Ford (F) rose, while Japanese competitors Toyota (TM) and Honda(HMC) fell.

Meanwhile, on the Nasdaq, Apple (APPL) jumped up 4.2% after Steve Jobs addressed rumored health concerns and announced that he will keep his position as CEO.

With this in mind, we thought we'd take a look at some of the stocks people have been searching for on TheStreet.com and see what Jim Cramer's had to say about them lately.

These stocks could be in the news for a number of reasons. Some require immediate attention while others may not. Regardless, it never hurts to hear what Cramer (or any of the other professional investors on the site) has to say about them. The key is to gather as much information as you can in order to make the most informed investment decisions you can.

In a recent post to his RealMoney blog, Cramer had this to say about Pfizer (PFE) and other pharma stocks:

"Did Pfizer say it is looking to short other drug companies' stocks? Did Pfizer say the group is overvalued? Too expensive to merge with? If you didn't read our Action Alerts PLUS note from this morning, you would hesitate to think beyond, 'Did someone downgrade the drug stocks?'

"To me this smacks of opportunity. Think about it like this: Oil's up, not because of demand (except for China perhaps) but because of Gaza. Because oil is up, the oils are up. Because the oils are up, people believe that the economy is strong. Because the economy is strong, it's right to buy the infrastructure stocks, the retailers and the oil service stocks!

"And here's Pfizer saying that it is looking to buy. To me, you have an opportunity to pick up some of these stocks, including the ones mentioned in a piece over on TheStreet.com, at prices you should not be able to get. The stocks are cheap, the economy's not strong -- here or worldwide -- and now you have a Pfizer catalyst. I would be willing to buy a basket of them, especially Bristol-Myers (BMY) but also Celgene (CELG), which is getting killed today!

"I think that these drug stocks should be bought on weakness, betting not that there is going to be a global economic recovery, just no global economic collapse. The idea, for example, that GM's sales weren't horrible, down 30%, does not make me want to go buy some Schlumberger (SLB) or some Ultra Pete (UPL).

"Read the piece. Buy one of the drug stocks. Gotta like one of these.

For more of what Cramer's had to say about Monday's top-searched stocks, including BP (BP), Boeing (BA), Genentech (DNA) and Applied Materials (AMAT), check out the Cramer's Take portfolio at Stockpickr.com.

(Editor's note: At the time of publication and/or original publication of his posts and shows, Cramer owned Bristol-Myers, BP and JPMorgan for his Action Alerts PLUS charitable trust.)

Posted on Jan. 6, 2009